Ascendis Pharma AS (MEX:ASNDN) Pretax Margin %: -19.54% (As of Mar. 2026)

What is Ascendis Pharma AS Pretax Margin %?

Ascendis Pharma AS MEX:ASNDN 37 Pretax Margin % is -19.54% as of Mar. 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, Ascendis Pharma AS ranks better than 64.1% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ascendis Pharma AS's Pre-Tax Income for the three months ended in Mar. 2026 was MXN-1,004 Mil. Ascendis Pharma AS's Revenue for the three months ended in Mar. 2026 was MXN5,141 Mil. Therefore, Ascendis Pharma AS's pretax margin for the quarter that ended in Mar. 2026 was -19.54%.

The historical rank and industry rank for Ascendis Pharma AS's Pretax Margin % or its related term are showing as below:

MEX:ASNDN' s Pretax Margin % Range Over the Past 10 Years
Min: -8127.44 Med: -1362.67 Max: -19.32
Current: -19.32

MEX:ASNDN's Pretax Margin % is ranked better than
64.1% of 947 companies
in the Biotechnology industry
Industry Median: -90.63 vs MEX:ASNDN: -19.32

Ascendis Pharma AS (MEX:ASNDN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Ascendis Pharma AS Pretax Margin % Related Terms

Ascendis Pharma AS Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Pretax Margin % Chart

Ascendis Pharma AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

-4,936.29

-1,129.12

-177.77

-102.64

-29.53

Ascendis Pharma AS Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Pretax Margin %	Get a 7-Day Free Trial															-92.68	-22.15	-26.86	-10.79	-19.54

MEX:ASNDN vs SMMT, BBIO, JAZZ: Pretax Margin % Comparison

For the Biotechnology subindustry, Ascendis Pharma AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Pretax Margin % falls into.

Save Embed

37GF Score

Ascendis Pharma AS MEX:ASNDN

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Ascendis Pharma AS Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ascendis Pharma AS's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4483.525	/	15183.233
	=	-29.53 %

Ascendis Pharma AS's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-1004.348	/	5140.904
	=	-19.54 %

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of -19.54% mean?

Ascendis Pharma AS (MEX:ASNDN) has a Pretax Margin % of -19.54% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ascendis Pharma AS and its competitors. According to the industry distribution chart, Ascendis Pharma AS ranks #340 out of 947 companies in the Biotechnology industry, placing it in the top 35.9%.

Is Ascendis Pharma AS's Pretax Margin % too high?

Ascendis Pharma AS's current Pretax Margin % is -19.54%. Based on the distribution chart, Ascendis Pharma AS ranks #340 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.

How does Ascendis Pharma AS's Pretax Margin % compare to SMMT and BBIO?

According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #340 out of 947 companies for Pretax Margin %. This puts Ascendis Pharma AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Pretax Margin % is -19.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ascendis Pharma AS stock overvalued right now?

Ascendis Pharma AS (MEX:ASNDN) has a current Pretax Margin % of -19.54%. The current Pretax Margin % is -19.54%. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current Pretax Margin % is -19.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Industry Healthcare Biotechnology

Comparable Companies SMMT BBIO JAZZ EXEL IONS AXSM MDGL BMRN ARWR CYTK VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ASND:USA

Address Tuborg Boulevard 12, Hellerup, DNK, 2900

Website https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

37GF Score

Get the complete analysis for MEX:ASNDN

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,851.44

Price

View MEX:ASNDN Analysis

See Pretax Margin % data for all stocks →